• Overview
  • News
  • Financials
  • Technicals
  • Peers
  • Shareholdings
  • MF
  • Corp Actions
  • About

Insights

We don’t have any Insights for this stock currently . We suggest you to explore other sections for more!

Returns

  • 1 DayN.A.
  • 1 WeekN.A.
  • 1 MonthN.A.
  • 3 MonthsN.A.
  • 1 YearN.A.
  • 3 YearsN.A.
  • 5 YearsN.A.

Financials

  • Income (P&L)

  • Balance Sheet

  • Cash Flow

  • Ratios

  • QuarterlyMar 2014Jun 2014Sep 2014Dec 2014Mar 2015
    Total Income241.58122.35212.46158.86153.12
    Total Income Growth (%)-38.28-49.3673.65-25.23-3.62
    Total Expenses244.03-94.16236.00197.38173.80
    Total Expenses Growth (%)-33.16-138.59-350.63-16.37-11.95
    EBIT-2.45216.51-23.54-38.51-20.69
    EBIT Growth (%)-109.29--110.87--
    Profit after Tax (PAT)-73.6396.55-46.87-83.56-46.02
    PAT Growth (%)---148.55--
    EBIT Margin (%)-1.01176.96-11.08-24.24-13.51
    Net Profit Margin (%)-30.4878.92-22.06-52.60-30.06
    Basic EPS (₹)-35.8547.01-22.82-40.69-22.41
    QuarterlyMar 2014Jun 2014Sep 2014Dec 2014Mar 2015
    Total Income113.3086.8692.3336.2625.44
    Total Income Growth (%)-18.91-23.346.30-60.73-29.85
    Total Expenses122.51-140.40118.9573.8155.11
    Total Expenses Growth (%)3.56-214.60-184.72-37.95-25.34
    EBIT-9.21227.26-26.62-37.55-29.67
    EBIT Growth (%)-142.99--111.71--
    Profit after Tax (PAT)-75.28109.03-46.93-72.99-51.21
    PAT Growth (%)---143.04--
    EBIT Margin (%)-8.13261.65-28.83-103.55-116.64
    Net Profit Margin (%)-66.44125.53-50.83-201.28-201.30
    Basic EPS (₹)-36.6653.09-22.85-35.54-24.93

    All figures in Rs Cr, unless mentioned otherwise

    No reported Profit & Loss Statement are available.

  • No reported Balance Sheet are available.

  • No reported Cash Flow Statement are available.

  • No reported Financial Ratios are available.

Financial InsightsElder Pharmaceuticals Ltd.

Do you find these insights useful?

  • hate it

  • meh

  • love it

Technicals

  • Buy / Sell Signals

  • Price Analysis

  • Pivot Levels & ATR

  • Chart

  • Stock doesnt have any Buy/Sell Signals.

  • Price Analysis Data details are not available.

  • Pivot Levels

    R1R2R3PIVOTS1S2S3
    Classic-------

    Average True Range

    5 DAYS14 DAYS28 DAYS
    ATR---

Peer Comparison

  • Stock Performance

  • Ratio Performance

  • Stock has no relevant peers for comparison.

  • Stock has no relevant peers for comparison.

Peers InsightsElder Pharmaceuticals Ltd.

Do you find these insights useful?

  • hate it

  • meh

  • love it

Shareholding Pattern

Shareholding details are not available.

MF Ownership

MF Ownership details are not available.

Top Searches:

Corporate Actions

  • Board Meeting/AGM

  • Dividends

  • Others
  • Meeting DateAnnounced onPurposeDetails
    Feb 03, 2016Jan 29, 2016Board MeetingQuarterly Results & Others
    Sep 28, 2015Sep 24, 2015Board MeetingOthers
    May 05, 2015Apr 29, 2015Board MeetingQuarterly Results
    Mar 24, 2015Nov 17, 2014AGMBC date has been revised from 22/12/2014 to 29/12/2014. (AGM date revised from 29/12/2014) (AGM revised from 31/12/2014)
    Feb 13, 2015Feb 13, 2015Board MeetingQuarterly Results & Others
  • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
    Final30%3.0Sep 17, 2012Aug 09, 2012
    Final 30%3.0Sep 15, 2011Aug 12, 2011
    Final 30%3.0Sep 16, 2010Aug 19, 2010
    Final 25%2.5Sep 17, 2009Aug 26, 2009
    Final 25%2.5Sep 18, 2008Aug 26, 2008
  • No other corporate actions details are available.

About Elder Pharmaceuticals Ltd.

  • Executives

  • Auditors

  • Executive details are not available.

  • Auditor details are not available.

More Details

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.

Write us

Find us at the office

Blotner- Kwas street no. 55, 39246 Canberra, Australia

Give us a ring

Dymon Rothfuss
+78 715 483 676
Mon - Fri, 10:00-22:00

Write us